Thursday, March 16, 2017
Corindus Vascular Robotics, Inc. announced that WakeMed Health & Hospitals will partner with Corindus to develop a national center of excellence to advance patient care and clinical robotics research and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions ("PCI") using the CorPath GRX System. WakeMed Health & Hospitals is the leading provider of health and cardiovascular services in Wake County, North Carolina.
"I am proud to be part of a health system that represents the best training, the latest technologies and the highest commitment to patient care, safety and innovation," said Frances O. Wood, M.D., FACC, interventional cardiologist and co-director of Structural Heart at WakeMed Heart Center. "CorPath GRX will transform the way we perform PCI, improving care and quality of life for our patients. I look forward to partnering with Corindus to build best-in-class medical education to train physicians and staff, to advance the body of clinical research on robotics, and to help shape the robotic system of the future."
WakeMed Health & Hospitals purchased three CorPath GRX Systems to develop a vascular robotics program. The CorPath GRX System is designed to treat patients undergoing PCI and builds on the CorPath platform with the addition of important key features that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. In addition, the System protects physicians and staff from the occupational hazards of working with radiation exposure in the cath lab.
Mark J. Toland, President and CEO of Corindus, stated, "Our top priority is to provide the best care possible for patients through precision medicine while protecting the physicians performing these life-saving procedures. Our partnership with leading clinical facilities such as the WakeMed Heart Center can accelerate the research, education and adoption of this important technology in cath labs across the United States."